Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


News In Brief

This article was originally published in The Gray Sheet

Executive Summary

Spectrum buys majority stake in Shaser Bioscience. Sorin snaps up Neurotech. Nihon Kohden acquires Defibtech. More news briefs.

You may also be interested in...

CMS Considers Expanded HIV-Screening Coverage

The Medicare agency has been asked to update its HIV-screening coverage policy to align with recent recommendations that all adults and adolescents be screened regardless of perceived risk.

St. Jude Warning Letter Adds More Pressure On Firm’s Leads Division

The company stresses that FDA’s letter does not identify any specific concerns about Durata or any other product, but the citation nonetheless states that the leads are “adulterated” due to quality system violations and “misbranded” due to adverse event reporting lapses.

News In Brief

McKesson buys PSS World Medical. St. Jude Medical draws FDA form 483. Cibiem raises $10 million for heart failure, hypertension treatment. More news briefs.

Related Content


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts